CIGARETTE-SMOKING RELATED POLYCYCLIC AROMATIC HYDROCARBON-DNA ADDUCTS IN PERIPHERAL MONONUCLEAR-CELLS

被引:94
作者
SANTELLA, RM [1 ]
GRINBERGFUNES, RA [1 ]
TIE, LY [1 ]
DICKEY, C [1 ]
SINGH, VN [1 ]
WANG, LW [1 ]
PERERA, FP [1 ]
机构
[1] HOFFMANN LA ROCHE INC,NUTLEY,NJ 07110
关键词
D O I
10.1093/carcin/13.11.2041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies on cigarette smoking related polycyclic aromatic hydrocarbon-DNA adducts in blood have produced conflicting results. To determine whether a subset of specific white blood cells is a useful marker for monitoring exposure to cigarette smoke, blood was obtained from 63 heavy smokers and 27 non-smokers. Adduct levels were determined by competitive enzyme-linked immunosorbent assay with a polyclonal antiserum recognizing benzo[a]pyrene and structurally related diolepoxide-DNA adducts. Analysis of the lymphocyte plus monocyte fraction from smokers indicated 70% had detectable adducts with a mean of 4.38 +/- 4.29 adducts/10(8) nucleotides, while in non-smokers the corresponding values were 22% and 1.35 +/- 0.78/10(8) (P < 0.001). Plasma cotinine levels differed significantly in smokers (286 +/- 90 mug/1) compared to non-smokers (4.4 +/- 3.3 mug/1) (P < 0.001). However, cotinine was not correlated with self-reported smoking history in these heavy smokers. Nor were DNA adducts in smokers correlated with cigarettes per day, pack-years and plasma cotinine, indicating large interindividual variation in DNA adduct formation. These data demonstrate lymphocytes plus monocytes from smokers have elevated levels of polycyclic aromatic hydrocarbon diolepoxide-DNA adduct levels compared to non-smokers.
引用
收藏
页码:2041 / 2045
页数:5
相关论文
共 35 条
[11]   P450 AND HUMAN CANCER [J].
KAWAJIRI, K ;
FUJIIKURIYAMA, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (12) :1325-1335
[12]   ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY AND BRONCHOGENIC CARCINOMA [J].
KELLERMANN, G ;
SHAW, CR ;
LUYTENKE.M .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (18) :934-937
[13]  
KOURI RE, 1982, CANCER RES, V42, P5030
[14]  
LIOU SH, 1989, CANCER RES, V49, P4929
[15]  
MACHACEK DA, 1986, CLIN CHEM, V32, P979
[16]  
MANCHESTER DK, 1992, CANCER RES, V52, P1499
[17]  
MEURET G, 1974, EXP HEMATOL, V2, P238
[18]   ROLE OF GENETICS AND DRUG-METABOLISM IN HUMAN CANCER RISK [J].
NEBERT, DW .
MUTATION RESEARCH, 1991, 247 (02) :267-281
[19]  
PERERA F, 1989, CANCER RES, V49, P4446
[20]   BIOLOGIC MARKERS IN RISK ASSESSMENT FOR ENVIRONMENTAL CARCINOGENS [J].
PERERA, F ;
MAYER, J ;
SANTELLA, RM ;
BRENNER, D ;
JEFFREY, A ;
LATRIANO, L ;
SMITH, S ;
WARBURTON, D ;
YOUNG, TL ;
TSAI, WY ;
HEMMINKI, K ;
BRANDTRAUF, P .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1991, 90 :247-254